Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Total Liabilities (2017 - 2025)

Selectis Health's Total Liabilities history spans 13 years, with the latest figure at $38.8 million for Q4 2025.

  • Quarterly results put Total Liabilities at $38.8 million for Q4 2025, changed 0.18% from a year ago — trailing twelve months through Dec 2025 was $38.8 million (changed 0.18% YoY), and the annual figure for FY2025 was $38.8 million, changed 0.18%.
  • Total Liabilities for Q4 2025 was $38.8 million at Selectis Health, roughly flat from $38.9 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $44.1 million in Q2 2023 to a low of $38.8 million in Q3 2024.
  • The 5-year median for Total Liabilities is $42.0 million (2022), against an average of $41.6 million.
  • The sharpest move saw Total Liabilities grew 5.53% in 2021, then fell 10.95% in 2024.
  • Year by year, Total Liabilities stood at $43.8 million in 2021, then fell by 5.21% to $41.5 million in 2022, then rose by 5.05% to $43.6 million in 2023, then decreased by 10.95% to $38.9 million in 2024, then dropped by 0.18% to $38.8 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $38.8 million, $38.9 million, and $40.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.